Navigation Links
World's Largest Soybean Processing Industrial Complex Converts Half of Capacity to Usage of Verenium's Purifine® PLC Enzymatic Degumming Process Engineered and Installed by Alfa Laval
Date:2/28/2011

SAN DIEGO, Feb. 28, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of high-performance specialty enzymes, today announced that Terminal 6, a major producer of soybean meal, oil and biodiesel, has successfully begun use of Verenium's Purifine enzymatic degumming process at its Puerto General San Martin facility in Argentina. Purifine enzymatic degumming is a novel process that significantly increases yields in edible oil production and can have additional benefits in refining the Purifine-degummed oil.

"Terminal 6 is a leading processor of soybeans, and a flagship plant for Bunge Argentina and Aceitera General Deheza," said Janet Roemer, President and Chief Operating Officer of Verenium.  "Verenium is pleased to be able to work with Terminal 6 to enable enhanced operating efficiency through the use of Purifine PLC. This implementation provides further validation of Verenium's Purifine technology to increase oil yields and improve the efficacy of meal production, and has been enabled by our partnerships with Alfa Laval and Bunge."

"Implementation of the Purifine PLC enzymatic degumming process has resulted in a significant increase in oil yields and processing margins enabling our facility to more fully reach its potential," said Enrique Humanes, Chief Executive Officer, Bunge Argentina.  "Successful installation of this process shows Bunge Argentina's continued commitment to leading edge process technologies that provide economic and environmental benefits."

"The implementation of Verenium's PLC technology at Terminal 6 combined with Alfa Laval's process, engineering and equipment supply capabilities, is the second large scale project we have completed together," said Bent Sarup,  General Manager of Alfa Laval's Vegetable Oil Technology activities. "Completion of the start up of Terminal 6's new process is fu
'/>"/>

SOURCE Verenium Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Ansell Launches Worldss First Antimicrobial Surgical Glove
2. BioSpace Highlights One of the Nations Largest Life Science Regions
3. LSU researchers awarded 1 of the largest NSF grants in Louisiana history
4. All-New Sermo Brings Major Enhancements to Nations Largest Online Physician Community
5. CardioCareLive, the Largest Online Cardiology Conference, Attracts 2,300 Attendees and Enjoys 92% Recommendation Rate
6. OriGene Technologies, Inc. to Build the Worlds Largest TrueMAB(TM) Monoclonal Antibody Facility in Wuxi, China
7. Beike Biotechnology Opens Worlds Largest Stem Cell Storage and Processing Facility
8. OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majority of Human Proteome
9. Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies
10. Nations Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate
11. DONG Energy and Inbicon Inaugurate One of the Worlds Largest Demo Plants for 2nd Generation Biofuel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... Massachusetts, USA (PRWEB) November 26, 2014 ... more accuracy, additive systems to enable 3D manufacture at ... analyzing road conditions are among finalists in nine categories ... . The awards are sponsored by SPIE, the ... Photonics Media . , Winners will be announced by ...
(Date:11/26/2014)... In keeping with the holiday spirit, DNA ... Thanksgiving savings. The company is offering up a variety ... this holiday weekend as well as a photo contest ... Monday are right around the corner, and DNA Spectrum ... and those looking to explore their ancestry, health, and ...
(Date:11/26/2014)... 2014 The ETC (Emerging Technology ... innovation centers, announced today that applications for AccelerateBaltimore™ ... 1st. “Do you have a big idea?,” asked ... to know about it. AccelerateBaltimore helps you and ... in just 13 weeks.” Interested game changers ...
(Date:11/26/2014)... 2014 Continuing its award-winning streak, Nerium ... prestigious MarCom Awards for outstanding creative achievement by its ... MarCom Award, the organization’s top honor, in the Branding ... held in April of this year. The event showcased ... Additionally, Nerium was awarded a Gold MarCom Award in ...
Breaking Biology Technology:Finalists Named for 2015 Prism Awards for Photonics Innovation 2Finalists Named for 2015 Prism Awards for Photonics Innovation 3Finalists Named for 2015 Prism Awards for Photonics Innovation 4Finalists Named for 2015 Prism Awards for Photonics Innovation 5DNA Spectrum Offers Last Minute Thanksgiving Coupons 2DNA Spectrum Offers Last Minute Thanksgiving Coupons 3AccelerateBaltimore Applications to Close in 6 Days 2AccelerateBaltimore Applications to Close in 6 Days 3Nerium International™ Wins One Platinum, Two Gold MarCom Awards 2
... FRANCISCO, March 11 VIA Pharmaceuticals,(Nasdaq: VIAP ... of,compounds for the treatment of cardiovascular disease, announced ... James G. Stewart, senior,vice president and chief financial ... Cowen and Company 28th Annual Health Care Conference ...
... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ), a clinical-stage ... of,novel small-molecule therapeutics, today reported financial results for ... Total revenue for the fourth quarter of ... $8.8 million. Total revenue for the year ended ...
... N.J., March 11 Pharmacopeia,(Nasdaq: PCOP ), an ... therapeutics, today announced that Dr. Leslie J. Browne,President and ... Cowen and Company 28th Annual Health Care Conference.,The conference ... The Boston Marriott,Copley Place, Boston, Massachusetts., Dr. Browne,s ...
Cached Biology Technology:Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 2Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 3Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 4Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 5Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 6Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 7Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 8Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 9Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 10Pharmacopeia to Present at the Cowen and Company 28th Annual Health Care Conference 2Pharmacopeia to Present at the Cowen and Company 28th Annual Health Care Conference 3
(Date:11/3/2014)... from Australia report that low birth weight and preterm ... hip replacements in adulthood. Findings published in the American ... Research , indicate that low birth weight and pre-term ... due to OA as adults. , According to ... 25 are diagnosed with clinical OA. Symptoms of OA ...
(Date:11/2/2014)... (2 November 2014)—In support of a bold quest to ... Melinda Gates Foundation today announced an award of US$156 ... Initiative (MVI) in building new vaccines that will interrupt ... the "accelerating to zero" agenda. Such vaccines would ensure ... be called an "immunological bed net." , This ...
(Date:11/2/2014)... a bar and bump into a biologist . . . ... late-night nerd sketch, researchers have taken this premise and applied ... finding meaning in the rising oceans of genomic data. , ... that genome-wide studies are publishing at a dizzying rate. The ... signal from the noise (and there is no shortage of ...
Breaking Biology News(10 mins):Preterm, low birth-weight babies may need new hips in adulthood 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 4Mutant models 2Mutant models 3Mutant models 4
... patients miserable and debilitated with chronic itching or pain ... possible paralysis or damage to the brain and other ... effective treatment even though the responsible gene was identified ... done to treat a disease that affects more people ...
... have identified a specific protein molecule that is used ... leading the way for development of future vaccines to ... issue of Science Express, the study provides insight into ... problem of great scientific and clinical importance. , Most ...
... field trials in China report higher crop yields, reduced ... a study by researchers in China and at Rutgers ... of the study will appear in the April 29 ... two of the four GM varieties that are now ...
Cached Biology News:Potential treatments for neurofibromatosis 2Potential treatments for neurofibromatosis 3Yale researchers identify molecule for detecting parasitic infection in humans 2Genetically modified rice in China benefits farmers' health, study finds 2Genetically modified rice in China benefits farmers' health, study finds 3Genetically modified rice in China benefits farmers' health, study finds 4